| Dr Mushtaq Ahmad Khan, | |
|
1410 N Horseshoe Dr, Sugar Land, TX 77478-3417 | |
| (281) 302-5756 | |
| (281) 990-6356 |
| Full Name | Dr Mushtaq Ahmad Khan |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 1410 N Horseshoe Dr, Sugar Land, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245232933 | NPI | - | NPPES |
| 0350310 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35037786 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mushtaq Ahmad Khan, 1410 N Horseshoe Dr, Sugar Land, TX 77478-3417 Ph: (281) 302-5756 | Dr Mushtaq Ahmad Khan, 1410 N Horseshoe Dr, Sugar Land, TX 77478-3417 Ph: (281) 302-5756 |
News Archive
Implanting dopamine generators (dopaminergics) in brain cells has produced improvement in the symptoms in Parkinson's, according to the results of tests carried out with monkeys by the Navarra University Hospital, led by Dr Mar'a Rosario Luquin Piudo, neurologist at the Hospital and at the other Navarra University-based medical centre, CIMA (the Research Centre for Applied Medicine).
The nonmedical use of prescription opioids (POs) has become an area of increasing public health concern in the United States and rates of use are particularly high among young adults. In the past decade, an emerging "epidemic" of nonmedical PO use has been reported.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
In a fascinating new preprint paper published on bioRxiv* in August 2020, the researchers report "the synthesis and antiviral evaluation of three novel lipophilic prodrugs of RVn-monophosphate that are substantially more active than Remdesivir in cells infected with SARS-CoV-2." These could be of immense use in treating COVID-19 patients early and helping to end transmission.
› Verified 2 days ago
Dr. Stephanie Florez-pollack, MD Dermatology Medicare: Medicare Enrolled Practice Location: 7616 Branford Pl Ste 240, Sugar Land, TX 77479 Phone: 281-240-4313 | |
Dr. Sunaina Bhuchar Likhari, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3533 Town Center Blvd S Ste 200, Sugar Land, TX 77479 Phone: 812-912-3425 | |
Dr. Keith E Schulze, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15400 Southwest Fwy, Suite 150, Sugar Land, TX 77478 Phone: 281-980-6647 Fax: 281-980-6650 | |
Dr. Miranda Adanna Ewelukwa, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1327 Lake Pointe Pkwy Ste 416, Sugar Land, TX 77478 Phone: 281-494-0050 | |
Dr. Lauren Allyson Snitzer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1327 Lake Pointe Pkwy Ste 416, Sugar Land, TX 77478 Phone: 281-494-0050 Fax: 281-494-0075 | |
Dr. Pamela Margaret Carr, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1111 Highway 6 Ste 160, Sugar Land, TX 77478 Phone: 281-494-0034 Fax: 281-494-0066 |